-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Genetically Engineered Myeloid Cells.

Program: Scientific Symposia
Session: Alternative Immune Effector Cells
Saturday, December 9, 2023, 2:00 PM-3:15 PM

James C Cronk, MD, PhD

NCI/CCR/POB, National Institute of Health, Bethesda, MD; Departments of Pediatric Oncology and Pediatric Hematology, Johns Hopkins University, Baltimore, MD

Disclosures: No relevant conflicts of interest to declare.

<< Previous Presentation | Next Presentation